The eatertainment brand saw same-store sales fall 7.7% last quarter, and failed to maintain a leverage ratio required by a financing covenant.
BTIG analyst Marie Thibault raised the firm’s price target on iRhythm (IRTC) to $135 from $120 and keeps a Buy rating on the shares after its ...
In a report released yesterday, Julian Harrison from BTIG maintained a Buy rating on Zealand Pharma (ZLDPF – Research Report), with a price ...
Gain exclusive insights into Leonardo DRS's Q4 2024 performance: record bookings, revenue growth, innovation investments, and a robust 2025 outlook.
When we spoke three years ago, your research was focused on the shopping center, net lease and health care subsectors. Is there anything new or different about your coverage universe here in 2025? Mr.
Wall Street is gearing up for another wave of blank check companies from seasoned and first-time sponsors, showing the ...
TipRanks on MSN2d
NeoGenomics price target lowered to $17 from $18 at BTIGBTIG lowered the firm’s price target on NeoGenomics (NEO) to $17 from $18 and keeps a Buy rating on the shares. Q4 results came in light “at an ...
When U.S. investors return from the long weekend they will be faced with a stock market looking well-positioned to break out to fresh record highs. But any such move into virgin territory may precede ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback